Treatment with Natalizumab in Relapsing-Remitting Multiple Sclerosis Patients Induces Changes in Inflammatory Mechanism

Author: Ramos-Cejudo Jaime  

Publisher: Springer Publishing Company

ISSN: 0271-9142

Source: Journal of Clinical Immunology, Vol.31, Iss.4, 2011-08, pp. : 623-631

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content